2,3,7,8-Tetrachlorodibenzo-p-dioxin induces liver lipid metabolism disorder via the ROS/AMPK/CD36 signaling pathway
Toxicological Sciences · 17.02.2023 · 191 (2) · 276-284
DOI: 10.1093/toxsci/kfac133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 19.12.2022. Verfasst von Yewen Cong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, P.R. China. Hauptthemen laut MEDLINE: Fatty Liver, Lipid Metabolism Disorders, Polychlorinated Dibenzodioxins. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is widely considered as the most toxic and common carcinogen in the world. Exposure to TCDD causes liver lipid metabolism disorder and steatosis. However, the molecular mechanism of TCDD-induced liver lipid accumulation is not completely clear. Here, we found that a 5 μg/kg TCDD exposure for 3 weeks induced hepatocyte lipid deposition, increased CD36 expression, and promoted AMP-activated protein kinase (AMPK) ɑ phosphorylation in the liver of C57BL/6J mice. Furthermore, sulfo-N-succinimidyl oleate, a CD36 inhibiter, blunted TCDD-induced lipid deposition in Huh7 cells, confirming the critical role of CD36 in TCDD-induced hepatic steatosis. In terms of molecular mechanisms, we found that TCDD exposure increased reactive oxygen species (ROS) levels in Huh7 cells, which activated AMPK. Moreover, the activated AMPK upregulated CD36 expression. Therefore, we can see that the increase in CD36 expression induced by TCDD was regulated by ROS/AMPK/CD36 signaling pathway. Our results help to clarify the molecular mechanism of TCDD-induced hepatic steatosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, P.R. China.
- Department of Clinical Nutrition, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, Jiangsu 226006, P.R. China.
- Haian Center for Disease Control and Prevention, Haian, Jiangsu 226600, P.R. China.
- Department of Clinical Nutrition, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221000, P. R. China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cong, Y., Hong, Y., Wang, D., Cheng, P., Wang, Z., Xing, C., Sun, W., & Xu, G. (2023). 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces liver lipid metabolism disorder via the ROS/AMPK/CD36 signaling pathway. Toxicological Sciences, 191(2), 276-284. https://doi.org/10.1093/toxsci/kfac133
Vancouver
Cong Y, Hong Y, Wang D, Cheng P, Wang Z, Xing C, et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces liver lipid metabolism disorder via the ROS/AMPK/CD36 signaling pathway. Toxicological Sciences. 2023;191(2):276-284. doi:10.1093/toxsci/kfac133
BibTeX
@article{Cong2023,
author = {Cong, Yewen and Hong, Yujing and Wang, Dandan and Cheng, Pei and Wang, Zhisheng and Xing, Changming and Sun, Wenxing and Xu, Guangfei},
title = {2,3,7,8-Tetrachlorodibenzo-p-dioxin induces liver lipid metabolism disorder via the ROS/AMPK/CD36 signaling pathway},
journal = {Toxicological Sciences},
year = {2023},
volume = {191},
number = {2},
pages = {276--284},
doi = {10.1093/toxsci/kfac133}
}
EUVIMED